[DNLI] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -5.07%
YoY- -45.58%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 35,141 42,141 7,923 3,604 4,205 641 0 -
PBT -109,781 -65,220 -70,041 -56,898 -38,992 -23,678 -21,320 31.39%
Tax -10,047 -1,278 -2,108 -135 0 0 0 -
NP -109,781 -63,942 -70,041 -56,763 -38,992 -23,678 -21,320 31.39%
Tax Rate - - - - - - - -
Total Cost 144,922 106,083 77,964 60,367 43,197 24,319 21,320 37.61%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -312.40 -151.73 -884.02 -1,575.00 -927.28 -3,693.92 0.00 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.80 -0.52 -0.58 -0.55 -0.41 -0.26 -2.36 -16.49%
EPS Diluted -0.80 -0.52 -0.58 -0.55 -0.41 -0.26 -2.36 -16.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.